More News! 13 Feb 2017
To the Rescue: A Final Phase III Success for Post-Operative Nausea
The dopamine antagonist Baremsis is on its way to FDA approval for the treatment and prophylaxis of post-operative nausea & vomiting, after succeeding in a final phase III study. Acacia Pharma, one…
